The UNODC SHERLOC portal is an initiative to help the dissemination of information regarding the implementation of the United Nations Convention against Transnational Organized Crime, the three Protocols thereto and the international legal framework against terrorism.
The Fourteenth Congress on Crime Prevention and Criminal Justice will be held in Kyoto, Japan from 20 to 27 April 2020.
United Nations Congresses on Crime Prevention and Criminal Justice have been held every five years since 1955.
Effectiveness Bank Analysis: Therapy ‘Toolbox’ Helps Rescue Poorly Recovering Patients at London Maintenance Clinic
Instead of a set programme, a clinic in London tried offering patients prescribed methadone or buprenorphine but still using heroin or cocaine a selection from a suite of well-supported psychological interventions tailored to the patient, and then systematically re-tailored in the light of how they responded.
Effectiveness Bank Analysis: Do Interventions to Reduce Alcohol-Related Harms also Reduce Domestic Abuse?
In celebration of International Women’s Day we are highlighting studies throughout the month of March that further our understanding of how sex and gender influence the course of addiction and treatment, with a particular focus on women.
At issue was whether by referring heroin users to treatment, probation services in England would protect them from fatal overdose and prevent drug-related crime. Yes to one, but not the other, were the answers; unexpectedly, crime went up. Enough to warrant abandoning treatment referral as a crime-prevention tactic?
Time to consolidate the lessons of the last five instalments of our course on drug treatment research. Row 5 explored key studies on treatment in relation to safeguarding the family and the community from crime.
Key studies on the roles of management in treatment’s impacts on crime and safeguarding the community, with a focus on criminal justice and child protection. Explore what research can offer managers who have to reconcile the interests of clients, their families and the community.
Opinion is sharply divided on the ethics and effectiveness of pressuring opioid-dependent offenders to take the opiate-blocker naltrexone. Especially sharp is the controversy over long-acting products not approved for medical use in the UK.